425: Silver Spike Investment Corp. Reports Mixed Q1 2024 Results Amidst Anticipated Cannabis Industry Shift

Silver Spike Investment Corp. announces Q1 2024 financial results, including a net investment loss of $(0.01) per share, while highlighting a potential positive impact from the DEA's move to reclassify cannabis.

Summary

• Silver Spike Investment Corp. (SSIC) reported its financial results for the first quarter ended March 31, 2024.
• Total investment income was $2.8 million.
• The company experienced a net investment loss of $(0.1) million, or $(0.01) per share, primarily due to $2.1 million in expenses related to the Loan Portfolio Acquisition.
• NAV per share decreased from $13.77 on December 31, 2023, to $13.60 on March 31, 2024, mainly driven by dividend payments.
• The company declared a cash dividend of $0.25 per share, payable on June 28, 2024, to stockholders of record on June 20, 2024.
• The company's investment portfolio had a fair value of $54.8 million as of March 31, 2024.
• As of March 31, 2024, the Company had $33.2 million in available liquidity, comprising $33.2 million in cash equivalents.
• The company anticipates an increase in cannabis capital markets activity in the second half of 2024 due to the potential reclassification of cannabis by the DEA.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company reported a net loss and a decrease in NAV, there are positive expectations regarding the cannabis industry and the company's ability to deploy capital.

Positives

• The company declared a cash dividend of $0.25 per share.
• The company anticipates an increase in cannabis capital markets activity in the second half of 2024.
• The company recorded a net unrealized gain of $0.6 million during the quarter ended March 31, 2024, primarily related to the fair valuation of our debt investments.
• As of March 31, 2024, there were no loans on non-accrual status.

Negatives

• The company experienced a net investment loss of $(0.1) million, or $(0.01) per share for Q1 2024.
• NAV per share decreased to $13.60 as of March 31, 2024, from $13.77 on December 31, 2023.
• Total expenses of $2.9 million exceeded total investment income of $2.8 million.

Risks

• The timing of the DEA's potential reclassification of cannabis is uncertain.
• The Loan Portfolio Acquisition is subject to customary closing conditions and may not be completed.
• The company faces risks related to changes in the economy, financial markets, and political environment.
• Elevating levels of inflation could impact the company and its portfolio companies.
• The company's ability to locate suitable investments and monitor them is subject to risk.
• The company faces strategic, business, economic, financial, political, and governmental risks.

Future Outlook

The company anticipates an increase in cannabis capital markets activity in the second half of 2024 due to the potential reclassification of cannabis by the DEA and expects to deploy capital to new portfolio companies with favorable risk/reward characteristics.

Management Comments

• Scott Gordon, Chairman and Chief Executive Officer of the Company, commented It was recently reported that the U.S. Drug Enforcement Administration (DEA) is moving to reclassify cannabis to a Schedule III substance under the Controlled Substances Act, a potential historic shift in federal regulation of the cannabis industry.
• Based on this news and an expected acceleration in refinancings, we anticipate an increase in cannabis capital markets activity in the second half of 2024.
• We believe that we will have the ability to deploy capital to new portfolio companies with favorable risk/reward characteristics for the foreseeable future, as the demand for capital will outweigh the supply.

Industry Context

The potential reclassification of cannabis by the DEA is a significant development for the cannabis industry, which could lead to increased capital markets activity and improved cash flow for cannabis operators. This announcement positions SSIC to potentially benefit from these industry shifts.

Comparison to Industry Standards

• It is difficult to compare SSIC's performance directly to industry standards without knowing the specific composition and risk profile of its loan portfolio.
• However, other BDCs focused on specialty lending, such as Ares Capital Corporation (ARCC) or Owl Rock Capital Corporation (ORCC), may serve as benchmarks for evaluating SSIC's performance in terms of investment income, expenses, and NAV per share.
• Given SSIC's focus on the cannabis industry, its performance should also be compared to that of other cannabis-focused investment firms, although direct comparables may be limited due to the unique regulatory environment.

Stakeholder Impact

• Shareholders will receive a cash dividend of $0.25 per share.
• Shareholders experienced a slight decrease in NAV per share.
• The potential reclassification of cannabis could positively impact portfolio companies and, consequently, the company's performance.

Next Steps

• The company will host a conference call and webcast on May 10, 2024, to discuss the Q1 2024 financial results.
• The company will proceed with the Loan Portfolio Acquisition, subject to customary closing conditions.
• The company will pay a cash dividend of $0.25 per share on June 28, 2024.

Key Dates